Microbix Biosystems (TSE:MBX) Trading Down 1.5% – Should You Sell?

Shares of Microbix Biosystems Inc. (TSE:MBX) traded down 1.5% during trading on Friday . The company traded as low as C$0.33 and last traded at C$0.33. 3,000 shares were traded during trading, a decline of 96% from the average session volume of 68,794 shares. The stock had previously closed at C$0.33.

Microbix Biosystems Trading Down 1.5 %

The company has a current ratio of 6.62, a quick ratio of 5.57 and a debt-to-equity ratio of 22.68. The company has a market capitalization of C$44.43 million, a price-to-earnings ratio of 8.13 and a beta of 0.34. The firm has a 50-day moving average price of C$0.32 and a 200-day moving average price of C$0.33.

Insider Buying and Selling at Microbix Biosystems

In other Microbix Biosystems news, Director Cameron Lionel Groome sold 220,000 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of C$0.33, for a total value of C$72,776.00. 14.00% of the stock is owned by corporate insiders.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.